This inventor holds 1 USPTO granted patent and 5 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Harvard College, University of California. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 3,078 
1 out of 16,035 
Years Active: 2024
Title: Andrew Kruse - Innovator in Muscarinic Acetylcholine Receptor Research
Introduction
Andrew Kruse is an accomplished inventor based in Palo Alto, CA. He is affiliated with Leland Stanford Junior University, where he contributes to the field of receptor research. Although he currently holds no granted patents, his work is significant in advancing therapeutic applications.
Latest Patent Applications
Andrew Kruse's latest patent applications include "Muscarinic Acetylcholine Receptor Binding Agents and Uses Thereof." This application describes agents that specifically bind to a muscarinic acetylcholine receptor in a conformationally specific manner. These agents can induce a conformational change in the receptor, which has therapeutic applications. They can also be utilized in X-ray crystallography studies of the receptor. Furthermore, these agents can enhance drug discovery through compound screening and structure-based drug design.
Conclusion
Andrew Kruse is making strides in the field of receptor research, focusing on muscarinic acetylcholine receptors. His innovative approaches have the potential to significantly impact therapeutic applications and drug discovery.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile